HighTower Advisors’s Array Biopharma Inc ARRY Stock Holding History

HighTower Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-400	Closed	-$2K	–	2576
2019 Q1	$2K	Sell	400 -100	-20%	-$2.08K	﹤0.01%	2263
2018 Q4	$1K	Hold	500	–	–	﹤0.01%	2201
2018 Q3	$1K	Buy	+500	New	+$7.66K	﹤0.01%	2278
2017 Q4	–	Sell	-600	Closed	-$1K	–	2432
2017 Q3	$1K	Buy	+600	New	+$5.57K	﹤0.01%	2214

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

HighTower Advisors's ARRY Position: Q3 2019 in Review

HighTower Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 14,866 shares — an estimated $690K sold.

HighTower Advisors first reported a position in ARRY in Q4 2013 and held it in 12 quarters. The position peaked at $3.01M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

HighTower Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
HighTower Advisors sold 14,866 Array Biopharma Inc shares in Q3 2019, an estimated $690K.
HighTower Advisors first reported a position in Array Biopharma Inc in Q4 2013 and held it in 12 quarters.
HighTower Advisors's Array Biopharma Inc position peaked at $3.01M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on HighTower Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.